Presentation is loading. Please wait.

Presentation is loading. Please wait.

BME treatment increases granzyme B expression in NK 3.3 cells.

Published byΕἰρήνη Δαγκλής Modified over 5 years ago

Similar presentations

Presentation on theme: "BME treatment increases granzyme B expression in NK 3.3 cells."— Presentation transcript:

1 BME treatment increases granzyme B expression in NK 3.3 cells.
BME treatment increases granzyme B expression in NK 3.3 cells. A, Western blot analysis of granzyme B expression in control or BME-treated NK3.3 cells when cocultured with Cal27 and JHU-29 cells. B, Phospho-STAT3/STAT3 expression in control or BME-treated NK3.3 cells cocultured with Cal27 was examined by Western blot using specific antibody. Similarly, lysates from NK cell were untreated or BME-treated were analyzed for phospho-STAT3/STAT3 expression. Blots were reprobed with an antibody to actin for comparison of protein loading in each lane. Densitometric analyses of was performed using ImageJ software. Data are represented as mean ± SD. *, P < 0.05; **, P < 0.01. Sourav Bhattacharya et al. Cancer Prev Res 2017;10: ©2017 by American Association for Cancer Research

Download ppt "BME treatment increases granzyme B expression in NK 3.3 cells."

Similar presentations

Fig. 5. Levels of apoptosis-associated proteins following treatment with parthenolide (PT) and balsalazide. HCT116 cell lysates were prepared after treatment.

Fig. 5. Levels of apoptosis-associated proteins following treatment with parthenolide (PT) and balsalazide. HCT116 cell lysates were prepared after treatment.
MEL23 and MEL24 inhibit Mdm2 and p53 ubiquitination in cells.

MEL23 and MEL24 inhibit Mdm2 and p53 ubiquitination in cells.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Pioglitazone inhibits aromatase expression in human preadipocytes.

Pioglitazone inhibits aromatase expression in human preadipocytes.
Role of HER2 in mediating acquired resistance to EGFR inhibition.

Role of HER2 in mediating acquired resistance to EGFR inhibition.
Overexpression of BTAK/Aurora-A in ovarian carcinoma.

Overexpression of BTAK/Aurora-A in ovarian carcinoma.
Mechanism of piperlongumine induced Sp downregulation.

Mechanism of piperlongumine induced Sp downregulation.
HIPK2 decreases the stability of Notch1-IC through proteasome-dependent degradation. HIPK2 decreases the stability of Notch1-IC through proteasome-dependent.

HIPK2 decreases the stability of Notch1-IC through proteasome-dependent degradation. HIPK2 decreases the stability of Notch1-IC through proteasome-dependent.
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.

Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.

Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.
Figure 4 DNM1 mutations affect protein levels and self-dimerization (A) HeLa cells were transfected with green fluorescent protein (GFP)-tagged mutant.

Figure 4 DNM1 mutations affect protein levels and self-dimerization (A) HeLa cells were transfected with green fluorescent protein (GFP)-tagged mutant.
Expression of cGMP signaling components in polyps.

Expression of cGMP signaling components in polyps.
Phosphorylation of AMPK-Thr172 before and after metformin treatment in muscle from subjects with type 2 diabetes. Phosphorylation of AMPK-Thr172 before.

Phosphorylation of AMPK-Thr172 before and after metformin treatment in muscle from subjects with type 2 diabetes. Phosphorylation of AMPK-Thr172 before.
CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.

CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.
Quantification of NMT knockdown.

Quantification of NMT knockdown.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.

TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)

Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)
Variation in dUTPase expression in cell lines.

Variation in dUTPase expression in cell lines.
FOXO3a phosphorylation and expression.

FOXO3a phosphorylation and expression.
The role of p53 in H2O2-mediated cell death of hOGG1-deficient H1299 lung carcinoma p53 null cells. The role of p53 in H2O2-mediated cell death of hOGG1-deficient.

The role of p53 in H2O2-mediated cell death of hOGG1-deficient H1299 lung carcinoma p53 null cells. The role of p53 in H2O2-mediated cell death of hOGG1-deficient.

Similar presentations

Ads by Google